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ABSTRACT
Introduction: Epidemiological studies suggest that
exercise has a tremendous preventative effect on
morbidity and premature death, but these findings
need to be confirmed by randomised trials. Generation
100 is a randomised, controlled study where the
primary aim is to evaluate the effects of 5 years of
exercise training on mortality in an elderly population.
Methods and analysis: All men and women born in
the years 1936–1942 (n=6966), who were residents of
Trondheim, Norway, were invited to participate.
Between August 2012 and June 2013, a total of 1567
individuals (790 women) were included and
randomised to either 5 years of two weekly sessions of
high-intensity training (10 min warm-up followed by
4×4 min intervals at ∼90% of peak heart rate) or,
moderate-intensity training (50 min of continuous work
at ∼70% of peak heart rate), or to a control group that
followed physical activity advice according to national
recommendations. Clinical examinations, physical tests
and questionnaires will be administered to all
participants at baseline, and after 1, 3 and 5 years.
Participants will also be followed up by linking to
health registries until year 2035.
Ethics and dissemination: The study has been
conducted according to the SPIRIT statement. All
participants signed a written consent form, and the
study has been approved by the Regional Committee
for Medical Research Ethics, Norway. Projects such as
this are warranted in the literature, and we expect that
data from this study will result in numerous papers
published in world-leading clinical journals; we will
also present the results at international and national
conferences.
Trial registration number: Clinical trial gov
NCT01666340.
BACKGROUND
Owing to worldwide increasing longevity, the
world population is rapidly ageing. It has
been estimated that the proportion of
people aged 60 years and older will double
from about 11% in 2000 to 22% in 2050, and
the age group 65 years and older will, for
ﬁrst time, outnumber children under the age
of 5 by 2017.1 In Norway, life expectancy in
women and men is predicted to increase by
10 years from 83 and 79 years, respectively,
over the next 80 years.2 Future demands for
healthcare services depend on illness and
disability in the older population. Active
ageing is a term used by WHO to describe
“the process of optimizing opportunities for
health, participation and security, in order to
enhance quality of life and wellbeing as
people age”, and includes delay of senes-
cence and compression of morbidity and
mortality.3 With societal expectances of an
increasing older population, interventions
that compress years with disability alongside
increased life expectancy are warranted.4
The ageing process is characterised by func-
tional and physiological changes, and
includes a decline in activity,5 mobility,6
Strengths and limitations of this study
▪ This study is the first randomised controlled trial
to evaluate the effect of exercise training on mor-
bidity and mortality in an elderly population.
▪ If proven beneficial, exercise as medicine is an
inexpensive, accessible and available treatment
with few negative side effects, for the ever-
growing ageing population.
▪ The study is unique due to the large sample size
included and because of the long intervention
period (5 years).
▪ Unfortunately, this study did not include partici-
pants who could not follow our exercise pro-
gramme due to safety concerns or disability.
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maximal oxygen uptake (VO2max)
7 and muscle mass.8 In
addition, the risk of most diseases, including type 2 dia-
betes,9 pulmonary diseases,10 cardiovascular diseases,11
cancer,12 and mental disorders such as depression and
dementia,13 all increases with age.14 15 Physical activity
and social engagement have been emphasised as import-
ant pathways to improve and maintain health in the
elderly.16 17 It has been shown that older people who
report being inactive reach a disability threshold
(deﬁned as needing help from another person to carry
out several daily-life activities) 14 years earlier than those
who report being highly active.18 Importantly, becoming
physically active even in older age seems to provide
health beneﬁts.19 Randomised, controlled trials have
shown that regular exercise training increases ﬁtness20 21
and reduces several of the traditional risk factors for car-
diovascular disease.22 23 It has also been shown that
high-intensity exercise training has the potential to
induce larger increases in VO2max and cardiovascular
function than low-intensity or moderate-intensity training
in healthy individuals,20 22 24 as well as in people with
metabolic syndrome23 and in those with hypertension,
and in patients with heart failure,25 intermittent claudica-
tion26 and coronary artery disease.27 28 However, redu-
cing traditional risk factors for disease does not
necessarily result in longer survival as it has been shown,
exempliﬁed by pharmacological interventions, that initial
improvements in surrogate markers are not able to show
corresponding effects on major end points.29 30 Multiple
epidemiological studies have suggested that physical activity
is associated with a reduced risk of premature death31–35
and that poor physical ﬁtness is a strong predictor of mortal-
ity.36–38 Even a small difference in ﬁtness appears to make a
substantial impact on survival.39 Furthermore, epidemio-
logical studies have suggested that physical activity is asso-
ciated with lower risk for developing diabetes,40
hypertension,41 depression,42 dementia,43 breast cancer,44
colon cancer45 and of accidental falls.46
Although many reports suggest that high physical activity
and ﬁtness may have favourable health effects, there is a
possibility that the level of physical activity is strongly corre-
lated with a person’s state of health, and may not be the
cause of it. Thus, there is a need for large randomised con-
trolled studies that can test the long-term effects of exer-
cise training on social participation, disability, disease and
survival in the general population. The Generation 100
study will be the ﬁrst large controlled randomised clinical
trial where the primary aim is to study effects of exercise
training on total mortality in an elderly population. The
present paper describes the design and signiﬁcance of the
Generation 100 study.
AIMS
Primary aim of Generation 100
▸ To determine the effects of regular exercise training
over a 5-year period on overall mortality in elderly
people (70–76 years of age).
Secondary aims of Generation 100
▸ To evaluate the effect of exercise training over a
3-year and 5-year period on social participation, phys-
ical function, cognitive function and overall morbidity
(new diagnosis and worsening of disease status).
▸ To evaluate the effect of high-intensity versus
moderate-intensity training over a 3-year and 5-year
period on traditional risk factors for cardiovascular
disease, maximal oxygen uptake, physical activity
level, pulmonary function, muscle strength, gait
speed and characteristics, need for prescription medi-
cations, falls and fall-related injuries, dementia,
depression, fatigue, rate of hospitalisation, and cost
and use of healthcare services (general physician,
nursing homes and home care).
▸ To increase the knowledge regarding genetic predispos-
ition for ﬁtness (VO2max) and cardiovascular diseases in
order to facilitate prevention strategies before symp-
toms appear. We also intend to identify potential thera-
peutic targets by searching for blood-borne factors
induced by training, using transcriptomics (messenger
RNAs and microRNAs) and proteomics arrays.
METHODS
Design
This is a phase IIb clinical trial, where the participants
are stratiﬁed by sex and marital status and randomised
1:1 into an exercise training group or to a control group
(ﬁgure 1). The exercise training group was further ran-
domised 1:1 into moderate-intensity or high-intensity
training. Inclusion started August 2012 and ended in
June 2013. The study will run until June 2018. The parti-
cipants are tested at baseline (before randomisation)
and at follow-up after 1, 3 and 5 years. The Unit for
Applied Clinical Research at the Norwegian University
of Science and Technology developed the randomisation
procedure to ensure impartial assignments. After ran-
domisation, participants received verbal and written
information about their intervention. Participant data
can be linked to the following registries until 2035:
Cause of Death Registry, Statistics Norway, Norwegian
Patient Register (NPR), National Injury Registry, Cancer
Registry of Norway, Norwegian Myocardial Infarction
Registry, National Population Register, GERICA (use of
municipal care services) and the Norwegian Prescription
Database. Generation 100 was registered in a clinical
trials registry in August 2012 (ClinicalTrials.gov,
Identiﬁer: NCT01666340). All protocol modiﬁcation
must be approved by the Regional Committee for
Medical Research Ethics, Norway. Participants are given
a project-speciﬁc code. This project code is used during
all analyses of the data. The procedures for data entry,
coding and storage have been developed in close collab-
oration with the Norwegian Data Inspectorate and the
Regional Committee for Medical Research Ethics,
Norway. The participants gave informed, written consent
to the main study and to receive invitations to
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substudies. Participation in the main study is not inﬂu-
enced by willingness to participate in substudies. All sub-
studies must have approval from the Regional
Committee for Medical Research Ethics, and studies will
not involve interventions that are in conﬂict with the
main study.
Settings and participants
This study is conducted in Trondheim, the third-most
populous municipality in Norway, with a population of
176 348 1 January 2012.47 Healthcare is provided pre-
dominantly by a public system, ﬁnanced through
general taxes, with no or nominal charge.48 All men and
women born from 1 January in 1936 to 31 December in
1942, with a permanent address in the municipality of
Trondheim (6966 people, 3721 women) were invited to
participate (ﬁgure 1). Potential participants were identi-
ﬁed through the National Population Register. An invita-
tion letter consisting of an informational brochure
about the study, a health-related questionnaire and a
response sheet with a consent form was sent to potential
participants. All individuals were asked to return the
response sheet with the consent form and the question-
naire independent of willingness to meet at baseline
examinations. Inclusion and exclusion criteria are given
in box 1. In total, 46% (3212) responded, 1422 were not
interested while 1790 consented to participate. Of the
1790 people who initially said they were interested, 49
persons were excluded, and 174 actively withdrew or did
not show up for testing. Thus, 1567 people, 777 men
(72.5±2.1 years) and 790 women (72.5±2.1 years) were
included (ﬁgure 1). Sample characteristics, based on
the questionnaire (see online supplementary ﬁle 1) sent
out with the invitation letter are shown in table 1. The
portion of sedentary behaviour is lower in the partici-
pants included in our study compared with those who
did not participate. Interestingly, 26% of those who did
not want to participate reported to be highly active
(almost every day), while the corresponding number
among the participants was 22%. In the non-
participating group, 32% reported to have higher educa-
tion (college/university), which is the same percentage
as for those who are 67 years and older in the general
Norwegian population.47 In the participating group,
50% reported to have higher education. In total, 87% of
the included participants and 66% in the non-
participating group reported to have good health. Thus,
the participants in our study are more active, have
higher education and better health compared with the
non-participating group. In Trondheim, the death rate
among those 68–72 years of age was 1.3% in 2010, and
among those 70–74 years old, 1.7%. In Norway, the age
Figure 1 Flow chart of
Generation 100.
Stensvold D, et al. BMJ Open 2015;5:e007519. doi:10.1136/bmjopen-2014-007519 3
Open Access
group.bmj.com on November 10, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
of retirement is 67 years, thus we wanted to include
people shortly after their working career ended. Initially,
people born between 1938 and 1942 (inclusive) were
invited. However, acceptance was lower than expected
and fewer than 1500 participants were enrolled in the
study. Therefore, in order to increase the sample size
according to power calculations (see below), we add-
itionally included those born in 1936 and 1937.
Ethics
The risk of exercise is considered very small; however,
the risk of complications/death is higher during and
immediately following training/testing.49 Nevertheless,
the health beneﬁts from exercise training are sufﬁciently
high and are considered less harmful than inactivity.
The control group will not have access to supervised
exercise training. However, they will be advised to follow
current national guidelines for physical activity and will
not take part in guided training. This reﬂects the ‘treat-
ment’ currently offered to the public. Providing sufﬁ-
cient clear information is a high priority, so that
participants feel that they know what consenting entails.
Examinations
Figure 2 shows the physical test battery and examinations
performed at baseline after 1, 3 and 5 years in all
groups. All test personnel were blinded for intervention.
Brieﬂy, four different questionnaires are used in this
study: Questionnaire 1 was sent out together with the
invitation letter, thus those who wanted to participate
and those who did not want to participate were both
asked to ﬁll out this questionnaire containing 21
health-related questions. Questionnaire 2 consisted of
more detailed questions about speciﬁc aspects of health,
lifestyle, social environment and family medical history.
The short form health survey SF-8 (1-week recall
version) is used to describe quality of life and chronic
pain (Q3). The questions from Q1, Q2 and Q3 have
Box 1 Inclusion and exclusion criteria
Inclusion criteria
▪ Born during 1936, 1937, 1938, 1939, 1940, 1941 or 1942.
▪ Able to complete the exercise programme (determined by the
researchers).
Exclusion criteria
▪ Illness or disabilities that preclude exercise or hinder comple-
tion of the study.
▪ Uncontrolled hypertension.
▪ Symptomatic valvular, hypertrophic cardiomyopathy, unstable
angina, primary pulmonary hypertension, heart failure or
severe arrhythmia.
▪ Diagnosed dementia.
▪ Cancer that makes participation impossible or exercise contra-
indicated. Considered individually, in consultation with
physician.
▪ Chronic communicable infectious diseases.
▪ Test results indicating that study participation is unsafe.
▪ Participation in other studies conflicting with participation in
Generation 100.
Table 1 Descriptive statistics of people included in the study and those who did not want to participate
Included Not participating p Values
Number of participants 1567 1361
Age (years) 72 73 <0.01
Height (cm) 172 (9) 171 (9) <0.05
Weight (kg) 75 (13) 76 (14) NS
College/university education (%) (SD) 50 32 <0.01
Current smoker (%) 9 12 <0.01
Self-reported health (%) <0.01
Poor 13 34
Good 87 66
Self-reported diseases (%)
Myocardial infarction 5 11 <0.01
Angina pectoris 3 7 <0.01
Heart failure 0.7 3 <0.01
Atrial fibrillation 6 12 <0.01
Diabetes mellitus 5 11 <0.01
Cancer 16 19 NS
Mental health problems 9 11 NS
Living condition, percentage of participants <0.05
Per cent living alone 25 29
Per cent living with others 75 71
PA, percentage of participants
Low 9 16 <0.01
Moderate 69 58 <0.01
High 22 26 <0.05
High, almost every day; low, less than once a week; moderate, 1–3 times per week; NS, non-significant (>0.05); PA, physical activity.
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many of the same questions that have been used in the
Nord-Trøndelag Health Study (HUNT).50–52 In addition,
the participants are also asked to ﬁll out a diet form
(Q4). Only those who were included in the study ﬁll out
questionnaire Q2–Q4. Blood samples are obtained from
an arm vein. Serum triglycerides, glucose, high-density
lipoprotein, total cholesterol, C reactive protein, glycosy-
lated haemoglobin (HbA1c) and c-peptide are mea-
sured immediately using standard procedures at St Olavs
Hospital, Trondheim, Norway. Serum and EDTA-treated
plasma are centrifuged at 3000 rpm for 10 min at 20°C.
Aliquots are stored at −80°C, in case new blood markers
will be analysed later. In addition, full blood from EDTA
is taken and stored (at Regional Biobank) at −80°C for
later DNA analysis. Blood pressure is taken in fasting
state at rest and immediately after exercise testing.
Testing of VO2max is performed on a treadmill identical
to that used in previous studies in our group,25 and par-
ticipants with previous heart diseases are tested under
ECG monitoring, and the American College of
Cardiology/American Heart Association (ACC/AHA)
guidelines for exercise testing of patients with known
cardiovascular disease is followed.53 Body composition
and weight are measured using bioelectrical impedance
(Inbody 720, BIOSPACE, Seoul, Korea). Gait character-
istics are measured by the GAITRite electronic gait mat
(CIR Systems Inc, Havertown, Pennsylvania, USA).54
Grip and leg strength were measured by the JAMAR
Hydraulic Hand Dynamometer (Lafayette Instrument
Company, USA) and a leg press machine (FCM 5540
Leg Press Rehab Standard, Helsinki University of
Research, HUR, Finland), respectively. Objectively mea-
sured physical activity is assessed by SenseWear Armband
activity monitor (BodyMedia 7, Pittsburgh, Pennsylvania,
USA) or by Actigraph (GT3X, Manufacturing Technology
Inc, Florida, USA). After the clinical test at the hospital, all
participants are given either SenseWear or Actigraph
monitor. The participants are instructed to wear it for
7 days continuously (24 h), except when in contact with
water (shower/bath/swim). The lung function tests are
performed with the Sensormedics Vmax22 Encore
(CareFusion, San Diego, California, USA) in accordance
with the American Thoracic Society/European
Respiratory Society (ATS/ERS) recommendations.55 56
Cognitive function and brain structure were tested using a
combination of questionnaires57 and MRI of the brain
using 3 T with 32 channel head coil and the following
protocol: three-dimensional T1-weighted ADNI, Flair, T2
and SWI volumes, and diffusion tensor imaging. Novel
genetic biomarkers(serum, plasma, DNA, RNA) will be ana-
lysed using high-throughput OMICS technology (genotyp-
ing or exome sequencing, DNA methylation, RNA
sequencing, microRNA screening, mass spectrometry-
based proteomics and MR metabolomics) using validated
methods established at Norwegian University of Science
and Technology’s Genomics, Proteomics and
Metabolomics Core Facilities. Health economic analysis
will be calculated as the sum of hospital cost (inpatient,
day care and outpatient care), use of general physician
and primary healthcare (rehabilitation, nursing homes,
home care, etc).
Sample size and statistics
Overall mortality was selected as the primary outcome
for the sample size calculation. For this purpose, the
exercise intervention groups (moderate and high inten-
sity) will be pooled and compared with the control
group. Epidemiological studies have reported a 50%
lower death rate after 14–16 years of follow-up in people
who are active compared with those who are inactive.34 58
In Trondheim (2010), 2% of the population between 70
and 77 years old died, and the expected mortality rate
after 5 years will be approximately 10%. With a power of
90%, about 600 participants are needed in each group
to detect a 50% reduction in mortality (ie, from 10% to
5%). We aimed to include 1500 participants to allow for
up to 20% of dropouts. It is unknown, however, whether
exercise has an effect on mortality. We therefore focus
Figure 2 Time points of
assessments and the outcome
variables measured.
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on the precision of the estimated absolute mortality
group difference in terms of the expected width of the
resulting CI for the true difference. With 750 partici-
pants in each group, the expected 95% CI width will be
between 0.05 and 0.06 depending on the observed mor-
tality in the intervention group (ﬁgure 3). We think this
precision is acceptable and emphasise that it does not
depend on whether the result is statistically signiﬁcant
or not. The comparisons of change between the groups
will be made by the intention-to-treat principle. Thus,
data will be analysed according to the group that partici-
pants are assigned to, regardless of possible crossover
and/or adherence to the intervention. In addition, we
will perform a per protocol analysis, based on adherence
to the intervention. The analysis will be made based on
whether participants have followed the prescribed inter-
vention or not. Non-adherence will be deﬁned as having
performed less than 50% of the prescribed training ses-
sions over the 5 years. Survival and morbidity analysis
will be carried out by performing χ2 and log-rank tests.
Cox regression analyses will be used to compute HRs of
all-cause mortality and onset of new diseases between
the groups. The precision of the estimates will be
assessed by 95% CIs. All statistical tests will be two-sided.
Interventions
High-intensity training
Participants randomised to high-intensity training are
asked to complete two weekly ∼40 min long workouts.
The participants are instructed to use a Borg 6–20 scale
(rating of perceived exertion) as guidance for exercise
intensity.59 They are supervised to perform a light
10 min warm-up, followed by 4 min working periods
(intervals) interspersed by 3 min active breaks. The
intensity during the intervals should be 85–95% of peak
heart rate, corresponding to approximately 16 on the
Borg scale.59 60 Breaks consist of working at an intensity
corresponding to ∼12 on the Borg scale (60–70% of
peak heart rate). Every sixth week the participants meet
for a supervised spinning session (ergometer cycling)
where they exercise with a heart rate monitor, to ensure
that they exercise at the recommended intensity, as
described above. In addition, organised training is
offered twice per week in different walking areas around
Trondheim. Attendance to these activities is voluntary,
and participants may choose to perform their exercise
training individually. The activity type performed will
vary between seasons of the year and includes indoor
and outdoor activities such as: walking/running, cross-
country skiing and aerobics.
Moderate-intensity training
To obtain isocaloric exercise, participants randomised to
moderate-intensity training are asked to complete
50 min of continuous moderate-intensity exercise corre-
sponding to 70% of peak heart rate (‘talking pace’)
twice a week.27 61 The participants are instructed to use
the Borg scale as guidance for exercise intensity, and the
exercise intensity should be perceived as approximately
13 on the Borg scale.59 60 The protocol regarding fre-
quency and type of exercise was the same as for the
high-intensity group.
Control group
The control group will be instructed to follow current
recommendations for physical activity in Norway,62
meaning 30 min of moderate-level physical activity every
day. No further supervision is given.
Adherence
Different strategies are used to improve and evaluate
adherence to exercise training. Participants in the exer-
cise groups are asked to ﬁll in exercise logs immediately
after each exercise session and send all the logs to the
research centre either in prepaid envelopes monthly, or
to use internet-based forms following each exercise
session.63 The procedures for reporting were prepared
after consulting the Regional Committee for Medical
and Health Research Ethics and the Data Inspectorate
of Norway. To increase motivation, spouses are rando-
mised to the same intervention group. The control
group reported their physical activity level once a year,
using a questionnaire. All participants are invited to an
information meeting once a year, and newsletters are
sent out twice a year. The participants can contact the
administration of the study by phone or email, and they
can ﬁnd all necessary information about the study and
the different interventions on the study’s homepage.64
An adherence committee was initiated after 1 year. The
committee will be responsible for implementing mea-
sures that increase adherence in the exercise groups,
such as arranging different activity events.
Figure 3 Sample size and precision (expected width of the
CI) for different mortality rates in the exercise group. The
chosen number (750 in each group) is shown as a horizontal
light grey line.
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Organisation
The steering committee of Generation 100 has devel-
oped the study protocol and is responsible for data col-
lection, management, publications and the ﬁnal data
set. All major scientiﬁc and ethical questions will be
resolved by majority vote. The committee is responsible
for ﬁnding solutions to unforeseen questions/problems
that arise in the course of the study. In addition, a Safety
committee, consisting of two physicians, will continuously
monitor the safety of the study and the study progres-
sion. The ﬁrst 300 included in the study ﬁlled out a
safety report 1 month after the initiation of the study. In
addition, participants ﬁll out a safety report every year
after the initiation of the training. The participants
should report if there has been: no special events, wor-
sening of disease, newly diagnosed disease, or if they
have been in the hospital. In addition, participants are
asked to classify the cause of the event to different dis-
eases/incidents. Furthermore, the Norwegian popula-
tion registry is checked every year to uncover
unreported mortality. Five times during the study, the
safety committee will evaluate if there are any differ-
ences in the number of events between the groups
(1 month, 1 year, 2 year, 3 year and 4 year), and continu-
ously evaluate if it is ethically justiﬁable to let the study
continue. Adverse advents during training and testing
will be reported to the safety department at the univer-
sity. The study has one physician (medical director),
who will take care of those participants suffering from
harm related to participation in the study.
Dissemination
Participants will receive their test result immediately after
the test. In addition, participants will be invited to an
annual meeting where general and new information will
be given. Providing sufﬁcient information to the partici-
pants is a high priority. It is anticipated that Generation
100 will garner widespread interest and media attention,
and will have results in a series of articles that will be pub-
lished in highly ranked international scientiﬁc journals.
DISCUSSION
To our knowledge, Generation 100 will be the ﬁrst study
with the primary aim of examining whether exercise has
an effect on mortality in an older population.
Generation 100 is unique because of the large sample
size, because the entire population is invited and
because of the long intervention period. The descriptive
data demonstrate that a larger portion of those who
were randomised reported better health, higher educa-
tion and less heart disease compared with those who did
not participate. However, the study consists of a diverse
group of elderly people, as healthy people and people
with many different diseases are both included. The
heart failure-action (HF-action) study was the ﬁrst large
(n=2331, average age 59 years, 661 females) randomised
study with the primary aim of evaluating the effect of
exercise alone on all-cause mortality and all-cause hospi-
talisation.65 In contrast to Generation 100, HF-action
only included patients with heart failure. After adjusting
for highly prognostic predictors, exercise training was
associated with a signiﬁcant, but modest, reduction in
mortality and hospitalisation.66 However, the interven-
tion in that study included only 36 supervised exercise
sessions, followed by home-based exercise, and, import-
antly, only 38% of the participants in the exercise group
fully adhered to exercise after 1 year.67 Exercise training
with high intensity has previously shown to induce
greater cardioprotective effect compared with moderate
exercise.22 27 47 68 To our knowledge, Generation 100
will be the ﬁrst study to evaluate the long-term effect of
both high-intensity training and moderate intensity on
how people age. Longevity seems to be an important
health goal for most western countries, and improved
health, increased self-reliance and preventing diseases
are highlighted as important strategies to reduce the
anticipated ﬁnancial burden of an ageing population.1 15
Data from Generation 100 will contribute to an
improved understanding and provide solutions on how
to achieve active ageing. Further, our data will demon-
strate if exercise can be used as a preventive intervention
for disease and functional decline, and give more and
healthier years to those who are systematically physically
active. If proven beneﬁcial, exercise as medicine will be
a relatively cheap, accessible and available treatment,
with few negative, but a large number of positive side
effects that can be offered systematically to a large
ageing population. The use of exercise as prevention
and treatment will potentially beneﬁt a large proportion
of the population, and may give a signiﬁcant economic
beneﬁt both at an individual level and from a societal
perspective. In conclusion, Generation 100 will give new
knowledge to whether exercise has an impact on mor-
bidity and mortality in elderly people, and further if
exercise training has an impact on several major health
issues that affect the elderly population. In light of the
ageing population, our data will hopefully contribute to
a better understanding of ageing, and serve as an
example of how to implement large health initiatives in
the future.
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